Chips · Stock report · Camtek (NASDAQ: CAMT)
Camtek — money-flow reading at -43.2 and rank 59 of 86 as the stock hits a new 52-week low
The Closelooknet read
Camtek (NASDAQ: CAMT) is falling with weak buying pressure behind it. Our money-flow reading (a gauge of net buying pressure) is -43.2, labelled cold and still accelerating down, after a drop of 39.4 points over 21 sessions. In the past month the stock lost 25.3%, which ranks 59th of the 86 stocks in our chip section. It closed at $89.20 on 20 November, below its previous 52-week closing low of $91.92 set on 5 November. We watch whether the money-flow reading climbs back from -43.2 and whether the stock holds above $89.20, or keeps sliding to further lows.
Where Camtek stands among 86 chip stocks
Camtek's one-month fall of 25.3% sits in the weaker half of our chip section. Among the testing and metrology peers in the pack, Teradyne (NASDAQ: TER) fell 33.7% and Advantest (6857.T) 29.6%. Ferrotec Holdings (6890.T) lost 26.3% and Aehr Test Systems (AEHR) 28.4%. Nova Ltd (NVMI) fell 9.4% and KLA Corp (KLAC) 14.2%. On the year to date Camtek is down 16.1%, while Nova is also down, by 14.5%; Advantest is up 23.5% and Technoprobe (TPRO.MI) up 78.6%. Camtek is 57.0% below its 11 May high of $207.46.
Our money-flow and quality readings
Our composite score for Camtek is 45 of 100. Momentum is the weakest reading at 12, followed by capital allocation at 22 and valuation at 27. Growth scores 54, quality 69, cash quality 72 and balance sheet 74. The Piotroski score, a check of financial health, is 5 of 9. The money-flow reading of -43.2 fell 10.7 points in the last five sessions, so the selling pressure is still building.
Price trend
Camtek fell 8.8% on 20 November and is down 12.3% over five days, 37.3% over three months and 10.8% over one year. The close of $89.20 is 30.6% below the 50-day average of $128.61 and 42.2% below the 200-day average of $154.21, the average close of the last 200 sessions. Its typical daily swing is about 4.5%. A stochastic signal turned up out of oversold on 19 November, a short-term momentum-turn signal.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.